Lv41
570 积分 2026-06-08 加入
Discovery of an orally bioavailable selenium-containing Polθ inhibitor with a dual mechanism of DNA damage and immune activation for HR-deficient cancers
21分钟前
已完结
Discovery ofLAS194046: A Potent and Selective pan-JanusKinase (JAK) Inhibitor with a Suitable Profile for Inhaled Administration
3个月前
已完结
Modality strategy in Eisai drug discovery: challenges toward next-generation therapeutics using proximity-inducing compound
5个月前
已关闭
Modality strategy in Eisai drug discovery: challenges toward next-generation therapeutics using proximity-inducing compound
5个月前
已关闭